Publication | Open Access
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma
75
Citations
16
References
2019
Year
P-AscH<sup>-</sup>/RT/TMZ is safe with promising clinical outcomes warranting further investigation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1